Can Fite Biopharma Ltd (CANF) — Financial Flexibility Index
Can Fite Biopharma Ltd (CANF) has a Financial Flexibility Index of -0.67x as of June 2025. Free cash flow of ILA-2.38 Million (operating CF ILA-2.38 Million minus capex ILA500.00) represents -1% of total liabilities (ILA3.54 Million). Check strategic asset allocation of Can Fite Biopharma Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Can Fite Biopharma Ltd Financial Flexibility Index (2010–2025)
Historical Financial Flexibility Index trend for Can Fite Biopharma Ltd across 16 annual periods. See Can Fite Biopharma Ltd (CANF) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Can Fite Biopharma Ltd (2010–2025)
Year-by-year free cash flow to debt coverage for Can Fite Biopharma Ltd. For the full company profile including market capitalisation, see Can Fite Biopharma Ltd (CANF) total market value.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.47x | ILA-9.68 Million | ILA-9.69 Million | ILA3.92 Million | ▼ -19.2% |
| 2024 | -2.07x | ILA-7.63 Million | ILA-7.64 Million | ILA3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | ILA-8.44 Million | ILA-8.44 Million | ILA3.75 Million | ▼ -0.4% |
| 2022 | -2.24x | ILA-10.79 Million | ILA-10.80 Million | ILA4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | ILA-9.85 Million | ILA-9.86 Million | ILA5.87 Million | ▲ +51.9% |
| 2020 | -3.49x | ILA-12.04 Million | ILA-12.06 Million | ILA3.45 Million | ▼ -84.7% |
| 2019 | -1.89x | ILA-10.83 Million | ILA-10.83 Million | ILA5.73 Million | ▼ -126.3% |
| 2018 | -0.83x | ILA-4.12 Million | ILA-4.16 Million | ILA4.94 Million | ▲ +58.1% |
| 2017 | -1.99x | ILA-9.52 Million | ILA-9.52 Million | ILA4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | ILA-8.92 Million | ILA-8.93 Million | ILA6.29 Million | ▼ -120.1% |
| 2015 | -0.64x | ILA-4.61 Million | ILA-4.65 Million | ILA7.16 Million | ▲ +70.7% |
| 2014 | -2.20x | ILA-7.32 Million | ILA-7.33 Million | ILA3.33 Million | ▲ +44.5% |
| 2013 | -3.96x | ILA-8.62 Million | ILA-8.63 Million | ILA2.18 Million | ▼ -113.6% |
| 2012 | -1.85x | ILA-4.34 Million | ILA-4.35 Million | ILA2.34 Million | ▲ +45.4% |
| 2011 | -3.40x | ILA-5.47 Million | ILA-5.50 Million | ILA1.61 Million | ▼ -413.1% |
| 2010 | -0.66x | ILA-3.62 Million | ILA-3.65 Million | ILA5.47 Million | — |